Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer
Endocrinología y Nutrición · 2016-04 · 63 (4) · e17-e24
DOI: 10.1016/j.endonu.2015.08.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinología y Nutrición, 2016-04. Verfasst von Garcilaso Riesco-Eizaguirre und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Hospital Universitario de Móstoles, Madrid, Spain. Electronic address: griesco@iib.uam.es. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Approximately one third of the patients with differentiated thyroid cancer (DTC) who develop structurally-evident metastatic disease are refractory to radioactive iodine (RAI). Most deaths from thyroid cancer occur in these patients. The main objective of this consensus is to address the most controversial aspects of management of these patients. METHODS: On behalf of the Spanish Society of Endocrinology & Nutrition (SEEN) and the Spanish Group for Orphan and Infrequent Tumors (GETHI), the Spanish Task Force for Thyroid Cancer, consisting of endocrinologists and oncologists, reviewed the relevant literature and prepared a series of clinically relevant questions related to management of advanced RAI-refractory DTC. RESULTS: Ten clinically relevant questions were identified by the task force. In answering to these 10 questions, the task force included recommendations regarding the best definition of refractoriness; the best therapeutic options including watchful waiting, local therapies, and systemic therapy (e.g. kinase inhibitors), when sodium iodide symporter (NIS) restoration may be expected; and how recent advances in molecular biology have increased our understanding of the disease. CONCLUSIONS: In response to our appointment as a task force by the SEEN and GHETI, we developed a consensus to help in clinical management of patients with advanced RAI-refractory DTC. We think that this consensus will provide helpful and current recommendations that will help patients with this disorder to get optimal medical care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Hospital Universitario de Móstoles, Madrid, Spain. Electronic address: griesco@iib.uam.es.
- Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
- Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain.
- Department of Endocrinology and Nutrition, Vall d'Hebron University Hospital, Barcelona, Spain.
- Medical Oncology Department, Santa Creu i Sant Pau University Hospital, Barcelona, Spain.
- Department of Endocrinology and Nutrition, Vírgen del Rocío University Hospital, Sevilla, Spain.
Zitieren
APA
Riesco-Eizaguirre, G., Galofré, J. C., Grande, E., Zafón Llopis, C., Ramón y Cajal Asensio, T., Navarro González, E., Jiménez-Fonseca, P., Santamaría Sandi, J., Gómez Sáez, J. M., & Capdevila, J. (2016). Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer. Endocrinología y Nutrición. https://doi.org/10.1016/j.endonu.2015.08.007
Vancouver
Riesco-Eizaguirre G, Galofré JC, Grande E, Zafón Llopis C, Ramón y Cajal Asensio T, Navarro González E, et al. Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer. Endocrinología y Nutrición. 2016. doi:10.1016/j.endonu.2015.08.007
BibTeX
@article{RiescoEizaguirre2016,
author = {Riesco-Eizaguirre, Garcilaso and Galofré, Juan Carlos and Grande, Enrique and Zafón Llopis, Carles and Ramón y Cajal Asensio, Teresa and Navarro González, Elena and Jiménez-Fonseca, Paula and Santamaría Sandi, Javier and Gómez Sáez, José Manuel and Capdevila, Jaume},
title = {Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer},
journal = {Endocrinología y Nutrición},
year = {2016},
doi = {10.1016/j.endonu.2015.08.007}
}
EUVIMED